Menu

Amgen and J&J were the latest drugmakers to issue refunds on 340B drugs in notices posted on the Office of Pharmacy Affairs website.

Amgen, J&J to Issue Refunds on High-Selling Drugs to 340B Providers

April 2, 2024 Rich Daly Editor in Chief Views

Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly